ACTRN12609000035224进行中（未招募）2 期
TOP GEAR: Trial of Preoperative Therapy for Gastric and Esophagogastric Junction AdenocarcinomaA randomised II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer
Australasian Gastro-Intestinal Trials Group (AGITG)0 个研究点目标入组 574 人开始时间: 2009年1月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 574
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Histologically proven adenocarcinoma of the stomach or gastroesophageal junction that is:
- •a. Stage IB (T1N1 only, T2N0 not eligible) – IIIC, i.e. T3 – T4 and/or N +ve, according to AJCC 7th edition.
- •b. Considered operable following initial staging investigations (surgeon believes that an R0 resection can be achieved).
- •(Gastroesophageal tumours are defined as tumours that arise in the cardia or at the GEJ that do not involve more than 2cm of the lower esophagus, i.e. Siewert Type II and Siewert Type III)
- •2. Age >= 18 years
- •3. ECOG performance status 0-1
- •4. Adequate organ function defined as follows:
- •Bone marrow: Haemoglobin >= 90 g/L
- •Absolute neutrophil count (ANC) >= 1.5 x 109 /L
- •White blood cell count >= 3 x 109 /L
- •Platelet count >= 100 x 109 /L
- •Hepatic: Serum bilirubin <= 1.5 x ULN
- •AST and/or ALT <= 3.0 x ULN
- •Renal: Serum creatinine <= 0.150 mmol/L, and calculated creatinine clearance >= 50mL/min.
- •5. Disease which can be radically treated with radiotherapy to 45 Gy with standard fractionation
- •6. Any patient with a history of ischaemic heart disease and abnormal ECG, or who is over 60 years of age should have a pre-treatment evaluation of cardiac function with a MUGA scan or echocardiogram. Patients will only be included if the left ventricular ejection fraction is >= 50%.
- •7. Written informed consent obtained before randomization.
- •8. Negative pregnancy test for women of childbearing potential within 7 days of commencing study treatment. Males and females of reproductive potential must agree to practice adequate contraceptive measures
排除标准
- •None of the following must apply:
- •1. Evidence of metastatic disease
- •2. Prior chemotherapy or radiotherapy
- •3. Patients with a past history of cancer in the 5 years before randomization except for the following. Patients with squamous or basal cell carcinoma of the skin that has been effectively treated, and patients with carcinoma in situ of the cervix that has been treated by operation only are eligible, even if they were diagnosed and treated within the 5 years before randomization.
- •4. Patients with other significant underlying medical conditions that may be aggravated by the study treatment or are not controlled.
- •5. Pregnant or lactating females or female patients of childbearing potential who have not been surgically sterilized or are without adequate contraceptive measures.
- •6. Cardiac failure and other contraindications to epirubicin.
- •7. Patients with impaired gastrointestinal absorption for whatever reason.
- •8. Patients medically unfit for cisplatin chemotherapy due to one or more of the following reasons:
- •a. Clinically significant sensori-neural hearing impairment (audiometric abnormalities without corresponding clinical deafness will not be regarded as a contraindication to cisplatin)
- •b. Severe tinnitus
- •c. Renal impairment (GFR<= 50ml/min)
- •d. Peripheral neuropathy => grade 2
- •e. Inability to tolerate intravenous hydration e.g due to cardiac disease
- •f. Co-morbidities (based on clinical judgement by the investigator) that in the view of the investigator would preclude the safe administration of cisplatin.
研究者
相似试验
已完成
2 期
Phase II trial in treatment of gastrointestinal fistulas with endoscopic injection of an alpha-cyanoacrylate monomerGastrointetinal fistulasJPRN-UMIN000018486Second Department of Surgery, Wakayama Medical University, School of Medicine20
尚未招募
不适用
A clinical trial to evaluate to GastroIntestinal protective eFfect of Tegoprazan for utilization of potent P2Y12 inhibitors in patients with Acute Coronary Syndrome (GIFT-ACS trial)Diseases of the circulatory systemKCT0007897Yonsei University Yongin Severance Hospital124
已完成
不适用
Clinical trial on the incidence of upper gastrointestinal mucosal injury induced by low-dose aspirin: a randamized control study using transnasal endoscopy in healthy volunteersupper gastrointestinal mucosal injuryJPRN-UMIN000001375Endoscopy Center, Tokyo Medical University Hospital40
已完成
不适用
Prospective Randomized Controlled Study of Gastric Emptying Assessed by 13C-Acetate Breath Test After Pylorus-Preserving Pancreaticoduodenectomy. Comparison between Antecolic and Vertical Retrocolic DuodenojejunostomyJPRN-UMIN000001712Department of Surgical Oncology and Regulation of Organ Function, Miyazaki University School of Medicine60
招募中
1 期
Clinical Study on the Treatment of Stage IV Gastric Cancer with De-Walled Ganoderma Spore Powder and ChemotherapyGastric CancerITMCTR2000003564The First Affiliated Hospital of Zhejiang Chinese Medical University